参考文献:1.World Health Organization (2009) Global tuberculosis control: epidemiology, strategy, financing. WHO Report. http://www.who.int/tb/publications/globalreport/2009/en/index.html Zugegriffen: 11. November 2015 2.Robert Koch Institut (RKI) (2013) Tuberkulosebericht 2013, Prävalenz von Tuberkulose in Deutschland. http://www.rki.de/DE/Content/InfAZ/T/Tuberkulose/Archiv_Berichte_TB_in_Dtl_tab.html . Zugegriffen: 11. November 2015 3.Ärztezeitung (2014) Tuberkulose unter Flüchtlingen. http://www.aerztezeitung.de/medizin/krankheiten/infektionskrankheiten/tuberkulose/article/896746/tuberkulose-gefahr-fluechtlingen . Zugegriffen: 11.11.2015 4.Roman A, Bravo C, Levy G, Monforte V, Vidal R, Sole J et al (2000) Isoniazid prophylaxis in lung transplantation. J Heart Lung Transplant 19:903–906CrossRef PubMed 5.Singh N, Paterson DL (1998) Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 27:1266–1277CrossRef PubMed 6.Malhotra KK (2007) Challenge of tuberculosis in renal transplantation. Transplant Proc 39:756–758CrossRef PubMed 7.Svobodová I, Honsová E (2015) Infections after kidney transplantation. Cesk Patol 3:120–122 (Abstract) 8.John GT, Thomas PP, Thomas M, Jeyaseelan L, Jacob CK, Shastry JC (1994) A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 11:1683–1684CrossRef 9.Naqvi R, Naqvi A, Akhtar S, Ahmed E, Noor H, Saeed T et al (2010) Use of isoniazid chemoprophylaxis in renal transplant recipients. Nephrol Dial Transplant 25:634–637CrossRef PubMed 10.Bansal N, Carpenter MA, Weiner DE, Levey AS, Pfeffer M, Kusek JW, Cai J, Hunsicker LG, Park M, Bennett M, Liu KD, Hsu CY (2015) Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial. J Am Soc Nephrol. doi:10.1681/ASN.2015030292 11.EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Transplantation 4:39–43
作者单位:Dr. L. Schneidewind (1) Dr. S. Schmidt (2)
1. Institut für Virologie, Universitätsklinikum des Saarlandes, Kirrberger Str. 100, 66424, Homburg/Saar, Deutschland 2. UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Kuno-Fischer-Straße 8, 14057, Berlin, Deutschland
刊物类别:Medicine
刊物主题:Medicine & Public Health Urology and Andrology